2016
DOI: 10.1002/rcr2.201
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary alveolar proteinosis: a case report and world literature review

Abstract: Pulmonary alveolar proteinosis (PAP) is a lung disorder which was first described in 1958 by Rosen et al. and is indeed rare disease with a prevalence of 0

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 30 publications
0
8
0
1
Order By: Relevance
“…In the Kingdom of Saudi Arabia, there have been reports of PAP due to surfactant clearance and surfactant dysfunction disorder 9,10. Nevertheless, this is the first report of PAP due to MARS mutation in the Arabian Gulf region…”
Section: Discussionmentioning
confidence: 77%
“…In the Kingdom of Saudi Arabia, there have been reports of PAP due to surfactant clearance and surfactant dysfunction disorder 9,10. Nevertheless, this is the first report of PAP due to MARS mutation in the Arabian Gulf region…”
Section: Discussionmentioning
confidence: 77%
“…The patient was supported on venovenous ECMO and bilateral whole-lung lavage was completed, with favourable outcomes and an improvement in hypoxaemia. H uaringa et al [ 17 ] described a case of a 52-year-old male with significant occupational exposure to silica, without use of personal protective equipment. He presented with exertional dyspnoea over 1.5 years, with a cough productive of white sputum.…”
Section: Discussionmentioning
confidence: 99%
“…The patient underwent whole-lung lavage (double-lumen endotracheal tube; dependent lung down) with ∼20 L. 1 week later, the second lung was lavaged. Overall, there was significant improvement in symptoms and oxygenation [ 17 ]. S tafford et al.…”
Section: Discussionmentioning
confidence: 99%
“…GM-CSF eksikliğinde veya yokluğunda alveollerde protein ve fosfolipid yapıda surfaktan birikimi olmaktadır. Bunlar göz önüne alınarak Huaringa ve arkadaşları tarafından PAP yönetiminde ilk olarak GM-CSF'nin denendiği ve total akciğer lavajının sadece GM-CSF'nin terapötik başarısızlığında kullanıldığı belirtilmiştir (18).…”
Section: Discussionunclassified